As more and more healthcare professionals are adopting EMR technology to meet Meaningful Use requirements, we are receiving more and more interest from dentists about adding clincial decision support technology into their dental practice management system. They are quickly realizing that Lexicomp is the preferred vendor of choice to work with, because we provide the very best dental specific drug database to integrate into their EMRs as well as personalized customer support during development. Another important piece to consider in a dental EMR is an ePrescribing tool. Lexicomp has a close partnership with DoseSpot to deliver this solution. By selecting DoseSpot for ePrescribing, our clients are able to get to the market faster and reduce their headaches in developing the tool on their own.
Lexi-Data provides the drug information for dose range checking, pediatric dosing, drug calculators, medicine interactions, dosage precautions, clinical guidelines, drug interaction software, duplicate therapy, drug classifications, generic drug names, drug nomenclature and more. These are critical paths for a dental EMR build.
To learn more about Lexicomp's dental solutions, please visit our website at http://www.lexi.com/individuals/dentistry/
If you are interested in learning more about our integration capabilities, we'd love to talk with you. Please contact us at 1-877-819-6883.
Lexicomp will be attending HIMSS 2012 in Las Vegas. This will be a great opportunity for any EMR, Hospital, or Consumer Health Site to visit booth #5134 and learn about our solutions for implementing decision support for drug interactions, duplicate therapy, drug allergies, and dose range checking, as well as
drug databases, and patient education information for consumers.
At
HIMSS 2012 there will be live demonstrations showing how our drug databases can be implemented and customized to meet the various specific needs of EMR vendors. Stop by and see us if you are a current customer or are looking to implement drug information or clinical decision support into your application.
Medication errors and
adverse drug events are serious issues in healthcare. Apprx 770,000 injuries or deaths related occur each year. For this reason and to comply with the certification and meaningful use requirements, every EMR should look at partnering with and providing their customers top rated drug interaction, duplicate therapy, allergy and dose range checking information integrated into their EMR. Lexicomp and the Lexi-Data product can offer this solution.
This information and its quality, customizability, and delivery format can really set your EMR apart from the competition. In 2010 the EMR market grew by almost 13.5% while competition in this area is also growing at a higher than predicted rate. More and more physicians are now starting to look at implementation of an EMR although the rate of adoption has been slowed by the complicated maze of meaningful use. None the less, it is critical that EMRs differentiate and help physicians understand how to navigate through this maze. Drug Data Vendors that are able to offer what others may not can help these EMR companies win more deals. Drug interactions that are cusomizable, dose range checking for specific populations (adult, pediatric, geriatric) duplicate therapy checking and an overall solid patient education offering are areas that can be easily implemeted from Lexi-Data. Lexicomp's expertise and customer service can also help get you up and running fast. The database is easy to work with, available in mutliple formats and even has a web-service set can help start up and established EMRs build the structure needed to help physicians.
For more information visit
www.lexi.com/businesses/ehr-vendors/
Are you looking to complete your clinical decision making process by imbedding quality and trusted drug data, complete with FDA Black Box Warnings directly into the workflow? If so, there are several options currently on the marketplace whether it be web based URLs (APIs), Web Services, or XML Datasets. Lexicomp can provide each option with drug - allergy checking, drug-drug interactions, duplicate therapy checking, and drug lists.
These options have the ability to intregrate directly into any hospital’s EMR, CPOE, pharmacy system, or Web portal. Still have questions, contact Lexicomp today to find out more about your options.
In the last several years that have been more and more EMR entrants into the ambulatory marketplace. As part of the development of these products they have been required to include drug information as part of their clinical decision support solution. Lately there have been more requests to provide this drug and medicine information by way of web services calls rather than embedding the data directly into the product. Often times there might be limitations on the EMR's development team and accessing this drug information through web services call could be the simpler solution.
Lexicomp recently released web services calls for drug information that would cover Meaningful Use Stage 1. So for EMRs in the development stage looking for:
- Drug - allergy checking
- Drug - drug interaction
- Duplicate therapy checking
- Drug lists
You might want to give Lexicomp a call.
EMR vendors are not the only ones rapidly deploying clinical decision support systems to healthcare providers. Dental professionals are demanding that their practice management systems overcome massive development hurdles in order to comply with Meaningful Use standards.
There is a buzz in the dental technology community about Meaningful Use and incorporating more clinical decision support into the practice management system workflow. If you are searching for the best dental specific drug database to integrate into your dental EMR, turn to Lexicomp. There are very few suppliers of drug data within the dental market and even fewer still that are easy to work with. And if you are looking for an easy-to-use, out-of-the-box ePrescribing tool, trust our partner DoseSpot to deliver the solution. What do all of these companies have in common? They are easy to work with and provide you with the ability to get to the market fast!
Don't wait to the end of your development process to worry about: dose range checking, pediatric dosing, drug calculators, medicine interactions, dosage precautions, clinical guidelines, drug interaction software, duplicate therapy, drug classifications, generic drug names, drug nomenclature and more. These are critical paths for a dental EMR build. But it's not just about the information. It's about who you select as your partner and who has seamless API's which makes your development easier.
You owe it to your product and your customer to make the right choice.
There have been thousands of articles written discussing why EMR adoption rates have been so low and why physicians especially have been resistant to moving into the electronic age. Little return on the initial investment, lack of efficiency in the system and no improvements in patient outcomes have been listed as reasons for reduced adoption rates.
One key element to the lack of efficiency and little improvement in patient care is due to the number of alerts that are generated when trying to use these systems. As a pharmacist, I enter in hundreds of medication orders in a shift and it is rare that I do so without receiving an alert from my HIS telling me about a drug interaction or duplicate therapy. These alerts although technically accurate, often involve medicine interactions that are so minor or irrelevant to hospital medicine.
If an HIS truly wants to improve patient care and become an indispensable part of medicine, it must provide clinical decision support that can accurately and appropriately give clinicians therapeutic alerts that are relevant and can help improve patient care. That is the goal of Lexi-Data. For more information about Lexi-Data, check out www.lexi.com.
Did you know that Lexicomp provides clinical decision support data needed for patient specific alerts (i.e. drug interactions, allergy, duplicate therapy and dose range checking) and to support sound treatment decisions in EMR products and e prescribing applications?
Lexicomp actively pursues relationships with companies that offer complementary products and services to allow for system integration. Through our HIS vendors such as Epic, Cerner, GE, Meditech, and others, clinicians can link directly to Lexicomp’s superior drug information, enabling them to make even faster, safer decisions while improving patient outcomes at the point-of-care.
If I had to venture a guess as to what features of Lexi-Data are most in demand by EMRs and their users, I would have to say that it has been:
-- Drug- Drug Interactions
-- Drug - Allergy Interactions
-- Dose Range Checking
-- Duplicate Therapy Checking
But now we are starting to see increased levels of interest in patient education and anything tied to eprescribing. And more and more developers are equally interested in the level of support they will receive from their partner vendor. There are quite often serious challenges that the developers will encounter during the project and it is important that they feel confident their drug data provider will be there when they need help.
I would suggest that either
Lexicomp or Cerner/Multum can deliver what you need when it comes to data. If you are looking for eprescribing, check out
DoseSpot. The DoseSpot folks are highly competent, reliable and knowledgeable.
The goal of policy makers in requiring the use of e-prescribing is to improve medication safety. Many systems have the ability to screen a new prescription for safety using clinical decision support tools such as drug interaction, drug allergy, duplicate therapy and dosage range checking. A recently published study by the Center for Studying Health System Change (HSC) analyzed the use of e-prescribing in physician practices and the impact on patient care. The study included 24 practices and found that while most e-prescribing systems used had access to patient medication information and clinical decision support tools built-in, only slightly more than half of the physicians reported accessing this information. Several reasons were cited for this low usage including the fact that it is difficult to import medication histories into the patient records and that physicians found little value in reviewing this information when making prescribing decisions.
The results of this study raise some interesting questions. The challenge of incorporating patient specific medication histories from multiple sources certainly is a real barrier and one that is pivotal to making CDS useful. Maybe more alarming is the perception that the alerts and checks that the system can provide are not useful in influencing prescribing decisions. This point can be challenging when e-prescribing systems are not built with reliable and clinically relevant data to power the CDS processes.
Lexicomp provides clinical information that can be used to perform key CDS functions such as drug interaction, drug allergy, duplicate therapy and dosage range screening. This content is derived from our well-established drug reference information that is evidenced-based, peer-reviewed and up-to-date. If you are a clinician working in health care, you most likely have relied on this content to help you make patient care decisions for many years. If CDS is going to accomplish its goal of improving patient care, it is going to require a strong, evidenced based library of clinical information. Something Lexicomp has been doing for over 30 years.
When integrated into your EMR, Lexicomp's drug reference content and drug interaction data will help you achieve the clinical decision support component of Meaningful Use.
Let’s face it: your customers need to prove Meaningful Use of their certified EMR in order to qualify to receive government incentive money. And if you don’t clearly communicate to users how your system will help them achieve Meaningful Use, you may get left behind.
So rest assured that when you implement Lexicomp's drug data and reference information, your EMR will be one step closer to complying with Meaningful Use! Lexicomp provides:
- Data for drug-drug, drug-allergy and drug-disease interaction screening
- Data to support duplicate therapy and dose range checking for pediatric and adult patients
- Data that allows users to generate patient-specific education handouts
For more information, go to
www.lexi.com/meaningful-use.
When reviewing a drug reference database provider, there are a number of factors to consider other than what functionality their product includes. While there are a number of vendors that provide clinical decision support like drug interaction, drug-allergy interaction, duplicate therapy, dose range checking, patient education leaflets, and other components of meaningful use, their quality of data may not be the same.
It is one thing to be able to check off a box that your EMR or ePrescribing application contains these features, but it is a different story when clinicians actually start to use your product. Implementation of one dataset maybe less expensive over another up front, but the cost of providing data that is deemed inaccurate or not valuable by your end users is extremely high as it can lead to alert fatigue and a distrust of your system.
Checking into the background of your drug reference database provider, the current customers using their content, and the past reputation of the vendor up front can prove invaluable down the road and lead to your users being happy and becoming champions of your product.
As hospitals and EMR vendors scramble to prepare for Stage I Meaningful Use criteria, the Stage II criteria are already being prepared. The Stage II requirements will require hospitals to continue with and advance the use of CPOE, and the use of clinical decision support elements including drug interaction and drug allergy screening. Additionally, patient education materials must be offered to at least 80% of patients at discharge.
Although most of these requirements are simply advancing a requirement from Stage I, the ultimate goal of requiring the use of clinical decision support tools is to improve patient care, especially as it relates to high priority health conditions. In order to accomplish this, CDS should have specific attributes: authenticated, credible, evidenced-based and patient-context sensitive. This can only be accomplished by using a drug reference database that can provide information that meets this criteria.
Lexicomp provides clinical information that can be used to perform key CDS functions such as drug interaction, drug allergy, duplicate therapy and dosage range screening. This content is derived from our well established drug reference information that is evidenced-based, peer-reviewed and up-to-date. If you are a clinician working in health care, you most likely have relied on this content to help you make patient care decisions for many years. If CDS is going to accomplish its goal of improving patient care, it is going to require a strong, evidenced based library of clinical information. Something Lexicomp has been doing for over 30 years.
I visited a tag sale this weekend and saw a lamp that intrigued me. Though it was an expensive brand, it was neither a beautiful lamp nor a particulalry useful lamp based on its shape. I couldn't stop thinking about this lamp but, in the end, I decided that it was more expensive than I was willing to pay and I'd come back on the next day to see if it was still there, knowing that tag sales typically mark down their items on the last day.
I visited the sale again on Sunday and imagine my surprise when I saw that the lamp had been marked up and was more expensive than when I had initially seen it! The sales staff were honest with me and told me that there had been so much interest in the lamp and so many people who said they were going to come back on Sunday, that they decided they'd raise the price.
As I said, this was neither an aesthetically pleasing lamp, nor was it particulalry useful, based on its awkward size and shape. Yet here they were, charging a premium for something that, from a utlititarian standpoint, did not warrant it; simply because they could.
Is your drug information provider charging a premium for sub-par (or at best, adequate) information? Does what you're getting really warrant what you're paying? Just because you're paying a premium for drug information for your EHR doesn't mean you're getting all that you need.
Lexicomp is not only a reasonably priced drug information provider, but can help by providing a medication list that includes both generic, brand name, and over-the-counter drugs. By providing drug interaction screening including drug-drug/drug-food/drug-herbal, dose range checking, and duplicate therapy screening, Lexicomp can help you as an EHR vendor, ensure your clients meet a number of Meaningful Use requirements.
Additionally, the Lexi-Data product is mapped to RXNORM and contains patient education information in up to 19 languages, which is another check box on the Meaningful Use requirements list.
So if you're looking for a drug information provider that can supply premium level content for a reasonable price,
check out Lexicomp. You won't be disappointed!
Several weeks ago I pointed out that an EMR or EHR vendor (or inside hospital HIS development team) overlooks some critical factors in making choices about drug data suppliers. No doubt the quality of the drug data is important, but that is just the beginning. These developers should be equally, if not even more, concerned about what I would call "softer" factors. such as:
1) Structure of the data (how easy is it to map to and identify?)
2) Availability and simplicity of the APIs offered by the vendor
3) How responsive is the drug information provider during the development period (this
will provide a major clue into how the long term relationship will work).
These might sound like simple things, but in the end, they are the most important things. Do your due diligence. Several years ago there were only a couple of drug data suppliers available. Now with the addition of the very well established drug information provider, Lexicomp, these development companies have a choice. Lexicomp has provided clinical decision support for three decades. It provides drug reference solutions to nearly 1500 hospitals in the United States, along with all divisions of the U.S. Military. The
Vancouver study released last year, rated Lexicomp Online as the most preferred drug database.
If you are looking for drug information or medicine data, Lexicomp can help by providing a medication list that includes both generic, brand name, and over-the-counter drugs. By providing drug interaction screening including drug-drug, dose range checking, and duplicate therapy screening, Lexicomp can help EHR vendors meet a number of Meaningful Use requirements. The Lexi-Data product delivered by Lexicomp is also mapped to RXNORM and contains patient education which is another check box on the Meaningful Use requirements list.
For too long, there were few choices of drug information providers for EMR, EHR and HIS vendors. It's not only a question of the quality of the drug and medicine information provided, but even more so it is an issue of the:
1) Structure of the data (how easy is it to map to and identify?)
2) Availability and simplicity of the APIs offered by the vendor
3) How responsive is the drug information provider during the development period (this
will provide a major clue into how the long term relationship will work).
These might sound like simple things, but in the end, they are the most important things. Do your due diligence. Check around.
Lexicomp provides drug reference solutions to more than 1500 hospitals in the United States, along with all divisions of the U.S. Military. The Vancouver study released last year, rated Lexicomp Online as the most preferred drug database.
If you are looking for drug information or medicine data, Lexicomp can help by providing a medication list that includes both generic, brand name, and over-the-counter drugs. By providing drug interaction screening including drug-drug, dose range checking, and duplicate therapy screening, Lexicomp can help EHR vendors meet a number of Meaningful Use requirements. The Lexi-Data product delivered by Lexicomp is also mapped to RXNORM and contains patient education which is another check box on the Meaningful Use requirements list.
According to a recent
report from KLAS, "35% of all respondents are replacing their EHR systems and 43% of physician practices with more than 100 doctors are doing so." What does that mean for EHR or EMR vendors? More sales, but only if you are ready. What is keeping you from these customers? If its drug data, then consider partnering with a trusted leader in drug databases for clinical decision support systems.
Consider Lexicomp
Lexicomp can help by providing a medication list that includes both generic, brand name, and over-the-counter drugs. By providing drug interaction screening including drug-drug, dose range checking, and duplicate therapy screening, Lexicomp can help EHR vendors meet a number of Meaningful Use requirements. The Lexi-Data product delivered by Lexicomp is also mapped to RXNORM and contains patient education which is another check box on the Meaningful Use requirements list.
A recent blog post by an EHR IT specialist outlines
20 different roles that a company developing EHR, EMR or HIS software must fill. The list is a sobering reminder of the vast array of tasks that EHR vendors must address before their product is ready for primetime use among healthcare providers.
Some of the roles on the list are general IT needs, like useability experts and database administrators. But others are unique to healthcare IT, like the ominous reference to "HL7 and healthcare data integration conformance engineers". That's the kind of specialized role that is both crucial to EHR development and subject to the greatest competitive pressures. What are the odds of finding an IT professional who can just glide into that role?
With many IT departments under-manned due to intense competition for talent and with so many "must-have" skill sets jockeying for those limited resources, many EHR vendors are making strategic decisions about where their tech staff should be spending its time. One way to free up resources is to partner with a drug information vendor that offers robust APIs which can speed the development of clinical decision support systems. Lexicomp is one such company that offers thorough API support for functionality like drug-drug interaction checking, drug-allergy interaction checking, duplicate therapy, and a myriad of reference look-ups. It's one quick way to get a jumpstart on much of the functionality required by HITECH "Meaningful Use" regulations.
Likewise, many EHR vendors are also adding on pre-certified ePrescribing or CPOE modules, rather than developing their own right now. These are "stand-alone" modules that already have SureScripts certification, and which can be integrated quickly into any EHR platform. DoseSpot is a good example of a company which can offer this.
Both of these options can ease the IT crunch and get your EHR market-ready sooner. Without these options, many EHR vendors may find themselves at the back of the pack when it comes time to sign up customers or qualify users for incentive dollars.
Powered by Compendium